ArticleCureus2026
Severe Uncontrolled Pancreatogenic Diabetes in a Patient With Prior Alcoholic Pancreatitis and Partial Pancreatectomy.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Pancreatogenic diabetes mellitus (type 3c diabetes mellitus, T3cDM) is an underrecognized form of secondary diabetes resulting from pancreatic exocrine disease, including chronic pancreatitis and pancreatic resection. It is frequently misclassified as type 2 diabetes mellitus, leading to delayed diagnosis and suboptimal management. We present a case of a 57-year-old female with a history of chronic alcoholic pancreatitis status post partial pancreatectomy who presented with severe uncontrolled hyperglycemia and medication nonadherence. Laboratory evaluation revealed a serum glucose of 668 mg/dL, hemoglobin A1c of 19%, and a low C-peptide level with normal insulin levels while receiving exogenous insulin, consistent with impaired endogenous insulin secretion and pancreatogenic diabetes. Despite repeated counseling and multiple attempts to optimize insulin therapy, the patient persistently refused insulin administration, resulting in refractory hyperglycemia throughout hospitalization. This case highlights the diagnostic challenges of distinguishing pancreatogenic diabetes from type 2 diabetes mellitus in patients with underlying pancreatic disease and emphasizes the importance of recognizing characteristic clinical features, including prior pancreatic injury and reduced endogenous insulin production. Early identification of T3cDM is essential because its pathophysiology and management differ substantially from type 2 diabetes mellitus and often require early insulin-based therapy to improve glycemic control and reduce long-term metabolic complications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.